Chat with London Hair System on WhatsApp
London Hair System company logo

London Hair System

Telogen Effluvium: Causes, Symptoms, Diagnosis and Recovery from Sudden Hair Shedding

This is an original article written by London Hair System. We hope readers find it useful and informative.

Please note that nothing in this article should be construed or interpreted as medical advice or professional advice. This article is for general information only. If you are experiencing any health concerns, we encourage you to consult with a qualified medical expert.

Something’s Coming Out in the Wash: Introduction to Telogen Effluvium

If you’ve ever stood in the shower, watching your hair gather in the drain with a sense of rising panic, you’re not alone, and you’re not imagining it either. Many people, especially women, experience sudden, excessive hair shedding at some point in their lives. It’s often brushed off as stress, vanity, or “hormonal stuff,” but the real explanation is typically more specific: a condition known as Telogen Effluvium (TE).

Despite being one of the most common forms of hair loss, TE flies under the radar. It’s rarely mentioned in casual conversations about alopecia. It doesn’t always make it into GP consultations. And in online forums, it’s routinely mislabelled as early female pattern hair loss, or even as some mysterious, irreversible thinning. In reality, TE is a defined clinical condition which affects millions globally, resolves in most cases, and has seen a measurable rise in incidence since the COVID-19 pandemic (Jae Joon et al., 2024).

TE isn’t a disease of the hair follicle itself. Instead, it’s a disturbance of the hair cycle; a kind of biological hiccup where large numbers of follicles shift into the resting (telogen) phase too soon, all at once. After a couple of months, they start shedding together. The result is diffuse hair loss. Not bald patches, not scarring, but a rapid and distressing increase in hair fall that often leaves the scalp feeling thinner, even if regrowth is quietly underway beneath the surface (Vogt, et.al., 2022).

While it can occur in men, TE predominantly affects women, particularly during hormonally sensitive periods like postpartum, perimenopause, and thyroid disruption (Malkud, 2015; NHS, 2023). It also has a peculiar time lag: the shedding doesn’t usually begin until 6 to 12 weeks after the triggering event. This delay often leaves both patients and practitioners puzzled, struggling to link the loss to its relevant cause. A fever, a crash diet, an emotional shock, or a medication switch from two months earlier might not seem relevant in the moment, but for hair follicles, the timeline checks out.

The COVID-19 pandemic offered a kind of unintentional case study. Dermatologists around the world began reporting a dramatic uptick in TE cases, not just among those with severe infections, but also among those who experienced psychological distress, disrupted routines, poor nutrition, or even asymptomatic viral exposure (Jae Joon et al., 2024). This isn’t a new phenomenon – post-infectious TE is well-documented in dermatology – but the scale was unprecedented, and it reignited interest in the broader triggers and trajectory of this neglected condition.

TE is almost always non-scarring and reversible, especially in its acute form. That doesn’t make it trivial. Hair shedding is deeply personal and highly visible. And when it’s misdiagnosed or poorly explained, it can drive people towards unnecessary treatments or exploitative “hair rescue” products. Worse, it can lead to real psychological distress, ranging from diminished self-esteem to full-blown anxiety disorders, especially when support is lacking or the impact of the condition is minimised. (Ross and Shapiro, 2004).

This article will unpack the science, diagnosis, treatment, and lived experience of Telogen Effluvium. We’ll trace its biological origins, outline what causes it, clarify how to recognise it, and examine what actually helps. Along the way, we’ll separate fact from fad, giving you the tools to understand what your hair might be telling you, and why now might be the moment to start listening.

The Hair Growth Cycle: How Hair Normally Falls Out

Before we can understand what goes wrong in Telogen Effluvium, we need to get a grip on what’s supposed to happen. Hair isn’t static. It doesn’t grow continuously or fall out randomly. Instead, it operates on a quietly choreographed cycle, which repeats itself over and over again across thousands of follicles on your scalp.

The typical scalp contains around 100,000 hair follicles, each operating independently. This independence is key: unlike seasonal animals who moult all at once, humans shed hair in a staggered fashion. At any given time, about 85 to 90 percent of your hair is in the anagen phase, which is the active growth period (Vogt, et.al., 2022). This phase can last two to six years, and it’s during this stage that your hair does all its visible lengthening.

Next comes catagen, a short transitional phase, which is like a kind of controlled shutdown. This lasts just a couple of weeks and affects only about 1 percent of hairs at any moment. It’s followed by the telogen phase, where the follicle takes a break. This “resting” stage lasts around three months, and during this phase, the hair shaft simply sits in place, neither growing nor being actively shed.

Finally, there’s exogen, the release phase, when the hair actually detaches from the follicle and falls out. Often this coincides with brushing, shampooing, or rubbing your scalp. Then the whole cycle begins again, usually without fuss.

Under normal conditions, you lose 50 to 100 hairs a day – a number that sounds high but barely dents your overall density. This daily shedding is physiologically healthy and balanced out by regrowth from follicles re-entering the anagen stage. But here is where Telogen Effluvium throws a spanner in the works.

In TE, an unusually large number of hairs are prematurely pushed into telogen at once — a phenomenon known as teloptosis. This isn’t due to follicle death, infection, or scarring. It’s simply a cycle misfire, often triggered by internal or external stressors (Headington, 1993). Because the telogen phase lasts a few months, the impact of that misfire isn’t immediate. The shedding starts later on, often just as the individual thinks things are calming down. It’s like getting hit with the delayed aftershock of an earthquake you didn’t realise had occurred.

It’s also worth noting that the appearance of hair loss doesn’t always match the biology. People with dark, long, or thick hair may notice shedding more dramatically than others. And if hair density is already reduced (from age, thinning, or recent pregnancy), even a small increase in shedding can feel enormous. That’s part of what makes TE so psychologically destabilising: it plays tricks not just with follicles, but with perception.

Still, the good news is this: TE does not damage the follicle itself. The machinery remains intact, primed to restart the cycle once the underlying trigger is addressed or resolves spontaneously (Vogt, et.al., 2022). That’s why, for many, TE is a temporary disruption and not a lifelong condition.

What Is Telogen Effluvium, and What Is It Not?

A diagnosis of Telogen Effluvium can sound deceptively straightforward. On paper, it’s described as a temporary, diffuse shedding of scalp hair following a shift in the hair cycle. But that definition barely scratches the surface. In practice, TE isn’t just misunderstood, it’s often mistaken for other conditions entirely, leading to unnecessary worry, ineffective treatments, or delayed support.

At its core, Telogen Effluvium is a reactive process, not a disease. It occurs when a significant number of anagen-phase hairs (the growing ones) are suddenly pushed into telogen (the resting phase) due to some form of physiological or psychological stressor. Several weeks later, those telogen hairs shed en masse (teloptosis). The result is a noticeable thinning across the entire scalp, often without obvious bald spots.

Clinically, TE is defined by both its pattern and timeline. The shedding is usually affects the whole scalp rather than forming round patches or receding temples. In its acute form, it begins two to three months after a trigger and lasts fewer than six months. Chronic TE, by contrast, persists for six months or longer and may occur in waves, with no clearly identifiable start point (Whiting, 1996).

The condition is also non-scarring, which is key. Unlike scarring alopecias, where the follicle is permanently damaged, TE leaves the follicle intact and capable of regrowth once the hair cycle resets. However, this regenerative potential doesn’t make TE easy to spot. In fact, it’s one of the most frequently misdiagnosed forms of hair loss, particularly in women.

Take female pattern hair loss (FPHL), for example. It shares some superficial similarities with chronic TE (for example, increased shedding and generalised thinning.) But FPHL typically presents with miniaturisation of hair follicles, visible density reduction at the crown or parting line, and a family history of gradual hair loss. TE, by contrast, often has a sudden onset, no clear pattern, and no prior signs of thinning (Lee et al., 2023).

Then there’s alopecia areata (AA), an autoimmune condition that leads to smooth, round bald patches and, in some cases, rapid total hair loss. Unlike TE, AA is patchy, unpredictable, and can affect brows, lashes, and body hair. These two conditions can occasionally coexist, but their causes, presentations, and treatments differ entirely (Ross and Shapiro, 2004).

The waters are muddied further by traction alopecia, trichotillomania, and androgenetic alopecia – all of which are distinct from TE in both mechanism and appearance. Yet in both general practice and online searches, these conditions are often lumped together under vague terms like “hair thinning” or “shedding,” which can add to the confusion.

That’s why a correct diagnosis hinges not just on a scalp exam, but on a careful patient history. Identifying a possible trigger, such as a recent illness, medication change, hormonal shift, or significant psychological event, is often more revealing than any test. In many cases, TE is diagnosed not just by what’s found, but by what’s ruled out (Mysore et al., 2020).

Still, even when properly diagnosed, TE rarely gets the attention it deserves. Because it doesn’t leave bald patches or permanent damage, it’s often minimised, and perceived as a cosmetic nuisance rather than a genuine medical concern. But for the person experiencing it, the daily reality can be relentless and difficult, featuring clogged drains, thinning ponytails, and the persistent fear that something more serious is going on.

Understanding what TE is (and what it isn’t) is the first step in managing it. It’s not irreversible. It’s not uncommon. And it’s not a sign of something fundamentally broken in the body. But it is real, it is disruptive, and when mistaken for other forms of hair loss, it can unfortunately send people down entirely the wrong path.

Why Now? Causes and Triggers of Telogen Effluvium

The thing about Telogen Effluvium is that it doesn’t just happen. Something nudges the system. And that “something” is often hidden in plain sight, an event or stressor that seemed unrelated at the time, only to show its effects two or three months later in your hairbrush. TE is fundamentally a response to disruption. The body, perceiving internal or external stress, shifts hair follicles from their active growth phase into rest mode. That shift is delayed rather than instant, so when the shedding arrives, the original trigger might already be a fading memory; but for the hair itself, the biology is still catching up.

Triggers can be grouped into a handful of broad categories, each with its own mechanisms, timelines, and degrees of impact.

Physiological Stress: Fevers, Surgery, Illness

This is arguably the most well-recognised cause. High fevers, major surgery, accidents, or serious infections (including flu, pneumonia, and COVID-19) frequently precipitate TE. These events place metabolic strain on the body and may temporarily redirect resources away from “non-essential” functions like hair growth (Malkud, 2015).

As mentioned previously, COVID-19 in particular became a global proving ground. The inflammatory response to COVID appears by itself to be sufficient to disrupt the hair cycle, even before lifestyle stress or nutritional depletion is taken into account.

Hormonal Shifts: Postpartum, Menopause, Thyroid

Hormones and hair have always had a complex relationship. During pregnancy, increased oestrogen levels extend the anagen phase — giving many women thicker hair. After birth, as hormones reset, a sudden and visible TE often occurs. Whilst this has been dubbed “postpartum hair loss”, physiologically it is textbook acute TE.

The same principle applies to perimenopause, when fluctuating oestrogen, progesterone, and sometimes androgens influence hair cycling. In some women, these shifts provoke a temporary TE; in others, they unmask underlying female pattern thinning (Malkud, 2015; NHS, 2023).

Meanwhile, thyroid dysfunction, especially hypothyroidism and hyperthyroidism, is a well-established trigger. Both over- and underactive thyroid states can shorten anagen and prolong telogen, resulting in a slow, persistent TE. Even well-managed thyroid disease can leave behind a trail of shedding (Mysore et al., 2020).

Nutritional Deficiency: Iron, Vitamin D, Crash Diets

Hair is metabolically active tissue. It needs fuel; not just calories, but specific nutrients.

Low ferritin (iron storage) is one of the most commonly linked deficiencies in TE. Research has consistently reinforced that, while there’s no universal agreement on the precise threshold, ferritin levels below 30 to 50 ng/mL are broadly considered suboptimal for hair growth, even when haemoglobin levels are normal, and this may contribute to hair cycle disruption (Boutros Soutou et al., 2024).

Likewise, vitamin D deficiency, common in darker-skinned individuals living at high latitudes, has been associated with TE-like shedding.

Sudden dietary shifts, extreme calorie restriction, and eating disorders can all induce TE, sometimes alongside other forms of hair loss. The hair, in essence, registers the nutritional shock as a reason to pause operations.

Drug-Induced Shedding

Certain medications are well-documented triggers of TE. These include:

The mechanism varies, but many of these drugs interfere with follicular cycling or protein synthesis. In most cases, the effect is temporary and resolves after dose adjustment or discontinuation, but not always (Alhanshali et al., 2023).

Importantly, with these causes, the latency period still applies: hair may begin falling out weeks after the start of a new medication, making the connection easy to miss unless the history is carefully mapped and analysed.

Psychological Stress: Grief, Trauma, Anxiety

Lastly, and perhaps most controversially, comes emotional stress. While not everyone accepts it as a standalone cause, substantial evidence, both clinical and anecdotal, supports the idea that grief, anxiety, or psychological trauma can provoke TE (Ross and Shapiro, 2004). The biological bridge between stress and TE is still under investigation, but proposed mechanisms include elevated cortisol levels, immune system modulation, and the indirect impacts via appetite changes, sleep disruption, or hormonal balance.

It seems our bodies can’t always distinguish between a physical threat and an emotional one, and either may be enough to pause hair production until further notice.

Trigger Stacking and Diagnostic Hurdles

In many cases, it isn’t just one cause, it’s two or three at once. A woman recovering from COVID-19 might also have low iron, be under chronic work stress, and have recently started a new medication. When triggers overlap, the hair responds cumulatively, not in silos. That’s why effective diagnosis often requires more than a single blood test. It requires contextual thinking, referring to a timeline, a lived experience, and work with a clinician who is willing to ask questions and search for clues, not just run clinical tests.

What TE Looks Like

Telogen Effluvium doesn’t look the way people expect hair loss to look. There are no bald patches, no shiny scalp, no neat circles of absence. Instead, it’s diffuse – a kind of all-over thinning that creeps up slowly, then suddenly feels overwhelming.

The classic presentation is increased daily shedding, often noticed during showering, brushing, or simply running fingers through the hair. The loss tends to be most visible at the temples, crown, and parting line, but not because these areas are more affected. These places are just where the scalp shows most easily when hair volume dips.

For many, the first sign is the intuitive realisation that there’s more hair in the drain than usual. It might not be dramatic from an outsider’s perspective, but for the person experiencing it, the contrast is stark. The ponytail feels thinner. The parting looks wider. Pillows and carpets seem to gather loose strands overnight.

What makes TE so challenging is that visual severity often doesn’t reflect actual damage. Because the hair follicles remain intact, and because regrowth typically begins within weeks of peak shedding, the overall density might stay within normal limits, even if it doesn’t feel that way (Headington, 1993).

Some dermatologists use the hair pull test as a quick clinical tool. This involves gently tugging a small section of hair to see how many strands come away. In healthy scalps, it’s usually fewer than three. In TE, it can be six or more, and usually all with white “club” roots attached, indicating hairs that are in the telogen phase (DermNetNZ, 2023).

A more objective option is the wash test, where hair is collected and counted after standardised washing. Shedding of over 100 hairs per day, consistently, may suggest active TE. However, these counts can vary based on hair length, texture, and washing habits. Many clinicians rely instead on patient history and a photographic comparison over time.

Importantly, generally with TE the scalp looks normal. There’s no redness, scaling, inflammation, or scarring. In some cases, short new hairs (called “regrowth spikes” or “baby hairs”) may become visible around the hairline, particularly if the TE episode is resolving. But these can easily be mistaken for breakage or damage, which can lead to more anxiety, not less.

From a patient perspective, TE feels anything but clinical. It’s emotional, frustrating, and deeply personal. Many individuals report compulsively checking their hairline in the mirror, inspecting brushes and shower drains, or photographing their scalp daily for signs of improvement or worsening. And, because TE often arises after a period of stress, illness, or hormonal shift, the person affected may already be vulnerable, physically depleted, or psychologically frayed. Hair loss, in that context, doesn’t just feel cosmetic. It feels like the final straw when so many other things have already gone wrong.

That’s why recognising the clinical pattern of TE, and being able to explain it clearly and empathetically, matters. Not every case needs medical treatment, but every case deserves to be taken seriously.

How It’s Diagnosed: “A Diagnosis of Exclusion”

There’s no single blood test or scan that can confirm Telogen Effluvium. Diagnosing it is more like detective work: a careful process of elimination that hinges as much on clinical instinct and patient history as it does on numbers in a lab report.

At its core, TE is a diagnosis of exclusion. That means other causes of hair loss must be ruled out before it can be confidently named. Scarring alopecias, autoimmune conditions like alopecia areata, fungal scalp infections, and patterned hair loss all have distinct presentations, and missing any one of those can lead to inappropriate management. But TE, when properly recognised, has a set of clues that usually add up.

History-Taking: The Timeline Tells the Story

The most powerful diagnostic tool is often a conversation. TE typically presents with sudden, diffuse shedding that begins 6 to 12 weeks after a triggering event. That event might be physical (like surgery, childbirth, or illness) or psychological (bereavement, burnout, trauma) – or both. Patients may not volunteer the information immediately because the lag creates a false disconnect. A skilled clinician will help reconstruct the timeline (Mysore et al., 2020) to move closer to diagnosis.

Questions around recent weight loss, infections, medication changes, hormonal shifts, and emotional stress can bring the picture into focus. If the timeline checks out, and the shedding is consistent with TE’s pattern, the diagnosis often becomes self-evident.

Physical Examination: Diffuse Shedding, Normal Scalp

On inspection, TE doesn’t cause visible inflammation, redness, or scale. The scalp is healthy and intact, with no scarring or ulceration. The loss is evenly spread, not patchy or following a specific pattern.

A hair pull test may show an increased number of club hairs coming away with gentle traction, particularly around the temples or crown. This is not definitive, but when positive, it supports the diagnosis of TE (DermNetNZ, 2023).

In some cases, short regrowing hairs may be visible along the frontal hairline. As mentioned previously, these aren’t breakage; they’re signs of recovery.

Laboratory Workup: Rule Out the Rest

Though there’s no diagnostic marker for TE itself, blood tests help rule out underlying contributors that either mimic TE or act as compounding triggers:

The goal here isn’t to “find” TE, rather it’s to make sure we’re not missing something else. If the results are within acceptable limits and the clinical picture fits, then TE remains the most likely explanation (Ross and Shapiro, 2004).

Advanced Testing: When It’s Not So Clear

In uncertain cases, especially where there’s overlapping hair loss (for example, both TE and early female pattern hair loss), trichoscopy or a trichogram may be used. These tools can assess hair shaft morphology, follicular density, and anagen-to-telogen ratios.

Biopsy is rarely required but may be considered in long-standing, atypical cases where scarring alopecia is suspected. It’s invasive, expensive, and not usually necessary for standard TE.

In short, diagnosing TE requires three things: a careful history, a clear pattern, and a process of elimination. It’s not high-tech, but thoughtful. And when done well, it prevents months of unnecessary worry, or worse, unnecessary treatments.

“Will It Grow Back?”: Prognosis and Recovery Timelines

Ask anyone dealing with Telogen Effluvium what they most want to know, and it won’t be the technical name or the trigger. It’ll be this: “Will my hair grow back?”

For most, the answer is yes. But the timeline, texture, and trajectory of regrowth can be unpredictable, and that’s where confusion can set in.

Acute vs Chronic TE: Different Timelines, Same Mechanism

In acute Telogen Effluvium, the prognosis is overwhelmingly positive. Once the initial trigger – illness, surgery, crash diet, childbirth – has concluded, the hair follicle cycle usually rebalances itself over time. Shedding tends to resolve within three to six months, followed by visible regrowth shortly thereafter (Whiting, 1996).

But TE doesn’t shut off like a switch. Even after the shedding slows, the scalp may still feel thin, and regrowth may come in soft, uneven, or wispier texture than before. These regrowing hairs – often seen as short, fine, frontal “baby hairs” – are signs of follicular reactivation, not damage.

In chronic TE, which lasts longer than six months, the outlook is still hopeful, although the condition may follow a more relapsing-remitting course. In some women, especially those with unresolved nutritional deficiencies, endocrine imbalances, or ongoing psychological stress, shedding may come in waves. Yet the follicles remain viable, and with the right interventions, many will regain hair volume over time (Whiting, 1996; Mysore et al., 2020).

What Recovery Actually Looks Like

Regrowth begins quietly. First, the follicle shifts from telogen to anagen. Then, a new hair bulb begins pushing up. From that point, it can take weeks to months before regrowth becomes noticeable, and six to twelve months before hair density feels “back to normal.”

Unfortunately this recovery lag can be psychologically punishing. Just as the shedding slows, patients expect immediate visual improvement. But hair grows only about 1 to 1.5 cm per month, and it takes time for shorter regrowing strands to match their neighbours. For those with long hair, full regrowth can take 18 to 24 months to visually blend in (Vogt, et.al., 2022).

Frustratingly, regrowth sometimes comes with texture or colour changes. Hair may feel finer, softer, or curlier at first. This is usually temporary, and the follicle readjusts as hair cycles stabilise.

When Recovery Stalls — or Doesn’t Happen

In rare cases, TE reveals another diagnosis hiding underneath. For example, chronic TE can unmask early androgenetic alopecia (female pattern hair loss), especially if there’s a family history. In others, persistent shedding may reflect an unresolved nutritional or endocrine issue, such as iron deficiency or subclinical thyroid dysfunction (Boutros Soutou et al., 2024). This is why tracking progress over 6- to 12-month intervals, ideally with photographs or trichoscopy, can be more useful than daily mirror checks.

Evidence for Interventions

While TE often resolves spontaneously, some interventions can speed recovery:

However, regrowth still requires time, patience, and reassurance. Quick fixes are rare. The follicles are doing the work, invisibly, and at their own pace.

Interventions: What Works, What’s Hype

When hair starts falling out, people understandably want something (or anything at all) to stop it. But Telogen Effluvium isn’t a condition that responds well to panic purchases or miracle claims. Because it’s a temporary disruption of the growth cycle, many interventions are either unnecessary, poorly targeted, or timed too early to have a visible effect.

That said, some interventions do help – not by “curing” TE, but by addressing underlying causes, supporting recovery, or preventing further disruption of the cycle.

Address the Underlying Cause First

There is no point applying serums or supplements if a trigger is still active. The first, most important step is to identify and correct what caused the TE in the first place.

In many cases, once the trigger is addressed, the body takes care of the rest.

Nutraceuticals with Evidence, and Those Without

Most over-the-counter hair supplements are long on promises and short on data. Biotin, for example, is included in many such products, but biotin deficiency is extremely rare in the general population, and supplementation offers no benefit to those who aren’t deficient.

However, one ingredient showing early clinical promise is a wheat polar lipid complex (WPLC). In a 2025 double-blind, placebo-controlled study of 99 women with acute TE, supplementation with WPLC led to statistically significant reductions in hair shedding and measurable increases in density over a 2–3 month period (Nobile et al., 2025). The trial, conducted independently of any brand, used a standardised polar lipid extract derived from wheat. While commercial formulations containing WPLC now exist, including those sold under brand names, it’s the ingredient itself, not any specific product, that was tested. The science on this is not definitive, and more studies are still needed. But it’s one of the few compounds with peer-reviewed, placebo-controlled data in a TE population, which is a rare distinction in the crowded supplement market.

Other compounds such as zinc, L-cysteine, or marine collagen are less well studied. Some may have value in specific deficiency contexts, but blanket use isn’t supported by strong data.

Minoxidil: Help or Hindrance?

Topical minoxidil – which is widely used in androgenetic alopecia – is sometimes turned to in TE cases. It stimulates hair follicles into the anagen phase and may accelerate regrowth. However, it can also increase shedding temporarily (as telogen hairs are pushed out to make way for new anagen growth), which can be extremely distressing if patients aren’t expecting it.

Minoxidil doesn’t treat the root cause of TE, and some experts suggest reserving it for cases where chronic TE overlaps with female pattern hair loss, or where visible density loss persists long after the shedding has resolved. It’s not routinely needed for acute TE.

Stress Management Isn’t Fluffy, It’s Physiological

Psychological stress is a known trigger and amplifier of TE. Yet it’s often treated as an afterthought. Mind-body interventions like CBT, meditation, yoga, or structured sleep hygiene can support hypothalamic–pituitary–adrenal axis recalibration — potentially improving hair outcomes indirectly (Ross and Shapiro, 2004).

That doesn’t mean telling someone to “just relax.” It means recognising that stress isn’t only emotional, but also biological, and that managing stress effectively is part of the recovery toolkit.

Myths, Gimmicks, and No-Gos

Avoid:

Ultimately, the most effective treatment for TE is time, supported by medical context and clarity. Where intervention is warranted, it should be tailored, grounded in science, and timed to fit with the hair cycle, avoiding rush or panic.

Living With TE: Emotional and Social Impact

For something that doesn’t scar, Telogen Effluvium can leave a deep mark. While the condition itself may resolve, the emotional toll it takes often lingers far longer than the shedding.

Hair isn’t just about biology; it’s wrapped up in identity, confidence, femininity, even normalcy. So when it begins to fall out in handfuls, the reaction is rarely mild. It can feel as if something is unravelling, not just on the scalp, but in one’s sense of self.

A Crisis Hidden in Plain Sight

Because TE doesn’t always cause bald patches or visible hairline recession, it’s often dismissed by others, by doctors, and sometimes even by the person experiencing it. Friends might say, “I can’t see it” or “it’s just hair”, without realising the mental determination involved in getting dressed, facing a mirror, or choosing not to cancel plans. Unlike alopecia areata or chemotherapy-induced loss, TE carries no obvious marker of medical legitimacy. That makes it uniquely isolating, and a silent condition in a world that often demands proof before offering sympathy.

Sadly, when help is sought, it’s not uncommon to encounter minimisation. In one survey of dermatology patients, women with diffuse hair loss reported feeling unheard or dismissed far more often than those with inflammatory or scarring alopecias (Ross and Shapiro, 2004).

The Psychological Weight of Shedding

For many, TE induces a kind of hyper-vigilance: a loop of checking, counting, inspecting, and comparing. A few extra strands in the brush can derail an entire day. What starts as shedding develops into an obsession. Some avoid washing their hair altogether out of fear; and others compulsively photograph their scalp in different lighting, trying to capture the invisible.

The condition doesn’t just feed anxiety – it feeds a specific kind of anxiety, which is rooted in a loss of control. You can’t “try harder” to stop TE. And that helplessness can easily bleed into other parts of life, affecting sleep, relationships, appetite, and mental health.

In extreme cases, prolonged TE may contribute to body dysmorphia, social withdrawal, or depressive symptoms, particularly when intersecting with postpartum, perimenopause, or recovery from illness. Yet formal support is rarely offered.

Support, Not Solutionism

Not every person with TE needs therapy. But validation should always be non-negotiable. Simply hearing, “Yes, this is real. Yes, it will end,” can be more therapeutic than any lotion or supplement.

Support groups, particularly those moderated by qualified professionals, can help reframe expectations and curb the spiral of self-monitoring. Online communities, while sometimes overwhelming, can offer solidarity if used cautiously.

Some find comfort in hair camouflage techniques: root powders, hair fibres, clever partings. Others choose to cut their hair shorter to reduce contrast in volume. These techniques can help close the gap between how an individual feels and what the world sees.

Language Matters

Clinicians play a pivotal role in how TE is perceived. Framing it as “just a temporary phase” may be biologically accurate but seems emotionally tone-deaf. Perhaps better to say: “It’s real. It’s disruptive. It’s reversible. And you’re not alone.”

TE is, after all, a shedding condition; but the person experiencing it shouldn’t be left to shed their confidence along with their hair.

What’s Next: Research and Emerging Directions

For decades, Telogen Effluvium has been the understudied stepchild of hair loss research, arguably overshadowed by its more visually dramatic cousins like alopecia areata and androgenetic alopecia. But that’s beginning to shift. A new generation of studies is starting to unpack the biology, biomarkers, and potential treatments that might reshape how TE is diagnosed and managed in future.

Understanding the Molecular Cascade

At the cellular level, TE involves a premature shift of anagen-phase follicles into telogen, but the signals that prompt this shift are still being elucidated. Inflammatory markers – particularly interleukin-6 (IL-6) – have emerged as potential players. IL-6 is a pro-inflammatory cytokine that modulates cell growth and immune response, and elevated levels have been linked to TE in several preliminary studies (Vogt, et.al., 2022).

Researchers are also exploring the role of oxidative stress, cortisol, and circadian disruption in telogen induction, especially in stress-related or post-infectious TE. These findings suggest that TE isn’t just a passive reaction to illness or trauma, but a biologically mediated response involving specific signalling pathways. Understanding these pathways could lead to targeted therapies, especially for chronic or treatment-resistant TE, although such interventions remain on the distant horizon.

Advances in Diagnosis: From Club Roots to Algorithms

As mentioned previously, diagnosis of TE still relies on history, inspection, and ruling things out. But that may soon change. Several research groups are working on trichoscopy-based diagnostic tools that use machine learning to differentiate TE from other diffuse hair loss conditions by analysing hair shaft thickness, follicular density, and telogen-to-anagen ratios.

Others are developing non-invasive scalp imaging devices that track density and growth over time, using smartphone-linked dermoscopy and AI interpretation. These innovations could allow earlier detection and more precise monitoring, and help with reducing the reliance on invasive biopsies or subjective clinical judgement (DermNetNZ, 2023).

Additionally, gene expression profiling of hair follicles has shown early promise in identifying telogen-predominant states, though this remains a research tool rather than a clinical one.

Recent attention has focused on bioavailable lipid complexes, like the wheat polar lipid formulation tested by Nobile et al. in a 2025 randomised controlled trial. In that study, participants not only showed reduced shedding, but also measurable increases in hair shaft diameter and growth rate, suggesting a direct impact on follicular function.

Other nutraceuticals under investigation include marine-derived peptides, plant-based anti-inflammatories, and nutrient transport enhancers. While much of this is still early-stage, the shift toward ingredient-level scrutiny and placebo-controlled design marks a welcome departure from traditionally vague, marketing-led supplements.

Post-COVID TE as a Catalyst for Better Research

TE finally landed on the radar of clinicians and researchers alike as a consequence of the pandemic. The sheer number of post-COVID TE cases – in men and women, across all ages and continents – provided an unprecedented data pool. Across dozens of studies, a surge in TE was reported among those infected with the virus, regardless of age, gender, or illness severity.

While prevalence estimates vary, modelling and observational data have suggested that between 10% and 30% of COVID-affected individuals experienced TE in the months that followed, with figures clustering around the 15–20% mark in some cohorts. One such study, a 2024 systematic review and modelling analysis supported the view that the pandemic triggered a global uptick in TE cases, not only through direct viral effects, but via psychological stress, disrupted sleep, dietary shifts, and immune system dysregulation (Jae Joon et al., 2024).

Reframing TE in Clinical and Public Conversations

Alongside molecular research and diagnostics, there’s a growing movement to change the narrative around TE. Rather than treating it as a vague or cosmetic complaint, clinicians are being encouraged to adopt a more structured and compassionate framework; one which recognises the physiological complexity and emotional burden of the condition.

Better GP education, clinical flowcharts, and decision-support tools are being developed to help non-specialists handle TE more effectively in primary care. This matters: most TE sufferers will never see a dermatologist. Their entire experience of the condition, from diagnosis to recovery, hinges on how well it’s understood at the front line of care.

In short, while TE has long been under-recognised, its moment in the spotlight may finally have arrived. From cytokines to computer vision, the future of TE care looks more evidence-based, more nuanced, and more hopeful than it has in the past.

Final Takeaways: What to Remember

Telogen Effluvium is not a mystery condition. It’s a predictable, biologically coherent response to stress – just one that happens to play out in your hairbrush instead of your bloodstream. And like most things hair-related, it’s easy to dismiss until it happens to you.

So, what should we hold onto, once all the strands are counted?

Most of all, TE teaches us that the hair cycle isn’t just cosmetic; it’s responsive, reactive, and deeply entangled with the rest of our biology. The follicles are listening. And sometimes, they’re telling us more than we think.

Thank you for reading.

References